Investing Profile

Chong Xu

InvestorVC
Partner at F-Prime Capital
fprimecapital.com/people/chon...Cambridge, Massachusetts
Photo of Chong Xu, Partner at F-Prime Capital Partners
Your Intro Paths to Chong Xu

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Chong is a member of
Moving Capital Network
963 CONNECTIONS
Moving Capital Network
963 CONNECTIONS
Moving Capital Network
963 CONNECTIONS
Moving Capital Network
963 CONNECTIONS
Moving Capital Network
963 CONNECTIONS

Find Chong Xu on

cb
Current Investing Position
F-Prime Capital Partners Partner
Investment Range
$100K - $10.0M
Sweet Spot
$5.0M
Investments On Record
8

Chong Xu is on these Sector & Stage Rankings

Chong Xu's Investments On Record (6)

CompanyStageDateRound SizeTotal Raised
R1 Therapeutics
Series AMar 2026$78M
$78M
Co-investors: Andrew Sinclair (Abingworth), Ben Auspitz (Curie.Bio)
OnCusp Therapeutics
Series AJan 2024$100M
$100M
Co-investors: Diyong Xu (OrbiMed), Karen Hong (De Novo Ventures)
K36 Therapeutics
Series BJun 2023$70M
Series ADec 2021$30M
$100M
Co-investors: Melissa McCracken (Nextech Invest), Jason Rhodes (Atlas Venture)
TandemAI
Series AMar 2023$35M
$35M
Sironax
Series BAug 2022$200M
Series ASep 2019$100M
$300M
RareStone Group (Previously Citrine Medicine)
Series AJul 2020$80M
$80M

Chong Xu's Experience

Healthcare Equity Analyst Moving CapitalPresent
Director Massif PartnersPresent
Director Moving CapitalPresent
MBA Class Of 2014 Darden School of BusinessPresent
MBA Class Of 2014 University of VirginiaPresent
Consultant Mckinsey & CompanyPresent
Associate Mckinsey & CompanyPresent
Board Observer Innovent Biologics（信达生物制药）Present
Board Observer Innovent BiologicsPresent
Board Observer Moving CapitalPresent
Board Observer Eyebright Medical TechnologyPresent
Board Observer Yisheng GroupPresent
Board Observer Semma TherapeuticsPresent
Board Observer Vertex PharmaceuticalsPresent
Director Board Of Directors Citrine Medicine / RareStone GroupPresent
Director Board Of Directors Moving CapitalPresent
Board Observer SironaxPresent
Board Observer LenoMedPresent
Director Board Of Directors AdagenePresent
Director Board Of Directors K36 Therapeutics, Inc.Present
Director Board of Directors OnCusp TherapeuticsPresent
Partner F-Prime CapitalPresent
Partner F-PrimePresent
Co-Founder, Investor, Board Director Geneception (Shanghai) Bio-technology Co.,Ltd. / Skyline TherapeuticsPresent
Co-Founder, Investor, Board Director Moving CapitalPresent

Chong Xu's Education

University of Virginia - Darden Graduate School of Business Administration Master of Business Administration (MBA) Business Administration and Management, General
University of Virginia Ph.D. Cell Biology
Zhejiang University B.S. Biological Sciences&Technology
National University of Singapore Visiting Student Institute of Molecular Agrobiology

Investors who invest with Chong Xu

Sign in with Google →

Scouts & Angels Affiliated With Chong Xu

Sign in with Google →